APA (7th ed.) Citation

McDonald, B. R., Contente-Cuomo, T., Sammut, S., Odenheimer-Bergman, A., Ernst, B., Perdigones, N., . . . Murtaza, M. (2019). Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer. Science translational medicine, 11(504), . https://doi.org/10.1126/scitranslmed.aax7392

Chicago Style (17th ed.) Citation

McDonald, Bradon R., et al. "Personalized Circulating Tumor DNA Analysis to Detect Residual Disease After Neoadjuvant Therapy in Breast Cancer." Science Translational Medicine 11, no. 504 (2019). https://doi.org/10.1126/scitranslmed.aax7392.

MLA (9th ed.) Citation

McDonald, Bradon R., et al. "Personalized Circulating Tumor DNA Analysis to Detect Residual Disease After Neoadjuvant Therapy in Breast Cancer." Science Translational Medicine, vol. 11, no. 504, 2019, https://doi.org/10.1126/scitranslmed.aax7392.